ArticleTherapeutic advances in medical oncology2020

Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.

Elisabetta Petracci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.